Ben Y. Parslow & Christopher R. Thornton. (2022) Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis. Microorganisms 10:6, pages 1208.
Crossref
Jonathan Spahr, Daniel J. Weiner, Dennis C. Stokes & Geoffrey Kurland. 2019. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children
923
943.e7
.
Liv Hesstvedt, Maiken C. Arendrup, Eira Poikonen, Lena Klingpor, Vanda Friman & Ingvild Nordøy. (2016) Differences in epidemiology of candidaemia in the Nordic countries – what is to blame?. Mycoses 60:1, pages 11-19.
Crossref
Riad Khatib, Leonard B. Johnson, Mohamad G. Fakih, Kathleen Riederer & Laurence Briski. (2016)
Current trends in candidemia and species distribution among adults:
Candida glabrata
surpasses
C. albicans
in diabetic patients and abdominal sources
. Mycoses 59:12, pages 781-786.
Crossref
Marya Zilberberg, Hsing-Ting Yu, Paresh Chaudhari, Matthew F Emons, Nikhil Khandelwal & Andrew F Shorr. (2014) Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study. Critical Care 18:5.
Crossref
Katsumi Shigemura, Kayo Osawa, Takumi Jikimoto, Hiroyuki Yoshida, Brian Hayama, Goh Ohji, Kentaro Iwata, Masato Fujisawa & Soichi Arakawa. (2014) Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection. The Journal of Antibiotics 67:4, pages 311-314.
Crossref
Lucas Ruiz Storti, Giuliano Pasquale, Rogério Scomparim, Ana Lúcia Galastri, Flávio Alterthum, Walderez Gambale & Claudete Rodrigues Paula. (2012) Candida spp. isolated from inpatients, the environment, and health practitioners in the pediatric unit at the Universitary Hospital of the Jundiaí Medical College, state of São Paulo, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 45:2, pages 225-231.
Crossref
Jonathan. Spahr, Daniel J. Weiner, Dennis C. Stokes & Geoffrey. Kurland. 2012. Kendig & Chernickâs Disorders of the Respiratory Tract in Children. Kendig & Chernickâs Disorders of the Respiratory Tract in Children
899
919
.
Michael A. Pfaller & Daniel J. Diekema. 2011.
Candida
and Candidiasis
.
Candida
and Candidiasis
449
480
.
Russell E. Lewis & Dimitrios P. Kontoyiannis. 2011.
Candida
and Candidiasis
.
Candida
and Candidiasis
373
385
.
Matthew E. Falagas, Nikos Roussos & Konstantinos Z. Vardakas. (2010) Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. International Journal of Infectious Diseases 14:11, pages e954-e966.
Crossref
Rana Traboulsi. 2009. Antifungal Therapy. Antifungal Therapy
278
292
.
Benoite Kaeser, Hagen Zandt, Fabrice Bour, Elke Zwanziger, Christophe Schmitt & Xiaoping Zhang. (2009) Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir. Antimicrobial Agents and Chemotherapy 53:2, pages 609-614.
Crossref
Maria-Cecilia Dignani, Joseph S. Solomkin & Elias J. Anaissie. 2009. Clinical Mycology. Clinical Mycology
197
229
.
David Trofa, Attila Gácser & Joshua D. Nosanchuk. (2008)
Candida parapsilosis
, an Emerging Fungal Pathogen
. Clinical Microbiology Reviews 21:4, pages 606-625.
Crossref
Jennifer K. Chow, Yoav Golan, Robin Ruthazer, Adolf W. Karchmer, Yehuda Carmeli, Deborah A. Lichtenberg, Varun Chawla, Janet A. Young & Susan Hadley. (2008) Risk factors for albicans and non-albicans candidemia in the intensive care unit*. Critical Care Medicine 36:7, pages 1993-1998.
Crossref
Jennifer K. Chow, Yoav Golan, Robin Ruthazer, Adolf W. Karchmer, Yehuda Carmeli, Deborah Lichtenberg, Varun Chawla, Janet Young & Susan Hadley. (2008)
Factors Associated with Candidemia Caused by Non‐
albicans Candida
Species Versus
Candida albicans
in the Intensive Care Unit
. Clinical Infectious Diseases 46:8, pages 1206-1213.
Crossref
George Dimopoulos, Fotinie Ntziora, George Rachiotis, Apostolos Armaganidis & Matthew E. Falagas. (2008) Candida Albicans Versus Non-Albicans Intensive Care Unit-Acquired Bloodstream Infections: Differences in Risk Factors and Outcome. Anesthesia & Analgesia 106:2, pages 523-529.
Crossref
Z. A. Kanafani & J. R. Perfect. (2008) Resistance to Antifungal Agents: Mechanisms and Clinical Impact. Clinical Infectious Diseases 46:1, pages 120-128.
Crossref
Chih-Cheng Lai, Che-Kim Tan, Yu-Tsung Huang, Pei-Lan Shao & Po-Ren Hsueh. (2008) Current challenges in the management of invasive fungal infections. Journal of Infection and Chemotherapy 14:2, pages 77-85.
Crossref
Beth A. Arthington-Skaggs & John H. Rex. 2008. Antimicrobial Resistance and Implications for the Twenty-First Century. Antimicrobial Resistance and Implications for the Twenty-First Century
325
369
.
Ricard Jordà‐Marcos, Francisco Álvarez‐Lerma, Maite Jurado, Mercedes Palomar, Juan Nolla‐Salas, María A. León & Cristóbal León. (2007) Risk factors for candidaemia in critically ill patients: a prospective surveillance study*. Mycoses 50:4, pages 302-310.
Crossref
Christopher C. Blyth, Pamela Palasanthiran & Tracey A. O'Brien. (2007) Antifungal Therapy in Children With Invasive Fungal Infections: A Systematic Review. Pediatrics 119:4, pages 772-784.
Crossref
Peter H. Michelson, Rakesh Goyal & Geoffrey Kurland. (2007) Pulmonary complications of haematopoietic cell transplantation in children. Paediatric Respiratory Reviews 8:1, pages 46-61.
Crossref
M. A. Pfaller & D. J. Diekema. (2007) Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem. Clinical Microbiology Reviews 20:1, pages 133-163.
Crossref
Peter G. Pappas. (2006) Invasive Candidiasis. Infectious Disease Clinics of North America 20:3, pages 485-506.
Crossref
Michael A. Pfaller, Peter G. Pappas & John R. Wingard. (2006) Invasive Fungal Pathogens: Current Epidemiological Trends. Clinical Infectious Diseases 43:Supplement_1, pages S3-S14.
Crossref
Carlos I Bustamante. (2005) Treatment of Candida infection: a view from the trenches!. Current Opinion in Infectious Diseases 18:6, pages 490-495.
Crossref
Brad J. Spellberg, Ashraf S. Ibrahim, Valentina Avenissian, Scott G. Filler, Carter L. Myers, Yue Fu & John E. EdwardsJr.Jr.. (2005)
The Anti-
Candida albicans
Vaccine Composed of the Recombinant N Terminus of Als1p Reduces Fungal Burden and Improves Survival in Both Immunocompetent and Immunocompromised Mice
. Infection and Immunity 73:9, pages 6191-6193.
Crossref
Lucía García San Miguel, Javier Cobo, Enrique Otheo, Aurora Sánchez-Sousa, Victor Abraira & Santiago Moreno. (2016)
Secular Trends of Candidemia in a Large Tertiary-Care Hospital From 1988 to 2000: Emergence of
Candida parapsilosis
. Infection Control & Hospital Epidemiology 26:6, pages 548-552.
Crossref
Mark J. DiNubile, Darcy Hille, Carole A. Sable & Nicholas A. Kartsonis. (2005) Invasive candidiasis in cancer patients: observations from a randomized clinical trial. Journal of Infection 50:5, pages 443-449.
Crossref
H. Agırbaslı, S. A. Keceli Özcan & Gündüz Gedikoğlu. (2005) Fecal fungal flora of pediatric healthy volunteers and immunosuppressed patients. Mycopathologia 159:4, pages 515-520.
Crossref
Frank C. Odds. 2005. Antibiotic Policies. Antibiotic Policies
311
330
.
Z. C. Karahan, H. Güriz, H. Ağırbaşlı, N. Balaban, J. S. Göçmen, D. Aysev & N. Akar. (2004)
Genotype distribution of
Candida albicans
isolates by 25S intron analysis with regard to invasiveness
. Mycoses 47:11-12, pages 465-469.
Crossref
Marc J. Struelens, Olivier Denis & Hector Rodriguez-Villalobos. (2004) Microbiology of nosocomial infections: progress and challenges. Microbes and Infection 6:11, pages 1043-1048.
Crossref
Sunit C. Singhi, Thimmapuram C. S. Reddy & Arunloke Chakrabarti. (2004) Candidemia in a pediatric intensive care unit. Pediatric Critical Care Medicine 5:4, pages 369-374.
Crossref
D. Swinne, M. Watelle, M. Van der Flaes & N. Nolard. (2004)
In vitro
activities of voriconazole (UK‐109, 496), fluconazole, itraconazole and amphotericin B against 132 non‐
albicans
bloodstream yeast isolates (CANARI study)
. Mycoses 47:5-6, pages 177-183.
Crossref
Peter G. Pappas, John H. Rex, Jack D. Sobel, Scott G. Filler, William E. Dismukes, Thomas J. Walsh & John E. Edwards. (2004) Guidelines for Treatment of Candidiasis. Clinical Infectious Diseases 38:2, pages 161-189.
Crossref
Janice (Wes) M. Y. Brown. 2003. Thomas' Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation
683
700
.
Sandra M. Swoboda, William G. Merz & Pamela A. Lipsetta. (2003) Candidemia: The Impact of Antifungal Prophylaxis in a Surgical Intensive Care Unit. Surgical Infections 4:4, pages 345-354.
Crossref
Roderick J Hay. (2003) Antifungal drugs used for systemic mycoses. Dermatologic Clinics 21:3, pages 577-587.
Crossref
M. A. Pfaller, S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis & D. J. Diekema. (2003)
Variation in Susceptibility of Bloodstream Isolates of
Candida glabrata
to Fluconazole According to Patient Age and Geographic Location
. Journal of Clinical Microbiology 41:5, pages 2176-2179.
Crossref
C. A. Mullen, H. Abd. El-Baki, H. Samir, J. J. Tarrand & K. V. Rolston. (2003) Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients. Supportive Care in Cancer 11:5, pages 321-325.
Crossref
D.P. Kontoyiannis, E. Mantadakis & G. Samonis. (2003) Systemic mycoses in the immunocompromised host: an update in antifungal therapy. Journal of Hospital Infection 53:4, pages 243-258.
Crossref
Johannes Müller, Annemarie Polak, Reinhard Kappe, Dagmar Rimek, Michael Seibold & Kathrin TintelnotAnnemarie Polak. 2003. Antifungal Agents. Antifungal Agents
59
190
.
Helen L. Leather & John R. Wingard. (2002) Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?. Current Opinion in Infectious Diseases 15:4, pages 369-375.
Crossref
Dominique Sanglard & Frank C Odds. (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. The Lancet Infectious Diseases 2:2, pages 73-85.
Crossref
R. Khatib, Kathleen M. Riederer, J. Ramanathan & J. BaranJrJr. (2001) Faecal fungal flora in healthy volunteers and inpatients. Mycoses 44:5, pages 151-156.
Crossref